Six Facilities Inaugurated Across Two States
EKA Mobility has inaugurated six manufacturing facilities spread across Madhya Pradesh and Maharashtra under a Rs 3,500 crore investment, as reported by ET Auto on 30 October 2026. The simultaneous inauguration of multiple plants across two states signals a significant capital commitment by the company in central and western India.
| Detail | Information |
|---|---|
| Promoter | EKA Mobility |
| Number of facilities | Six |
| Locations | Madhya Pradesh and Maharashtra |
| Total investment | Rs 3,500 crore |
| Event | Inauguration |
| Reported by | ET Auto, 30 October 2026 |
Maharashtra and MP in the Broader Industrial Project Pipeline
The two states where EKA Mobility has invested feature prominently in India's industrial project pipeline. Maharashtra in particular is an active location for pharmaceutical and manufacturing investment. Projects India tracks 169 drugs and pharmaceuticals projects in Maharashtra, making it the fifth most active state in that sub-sector by project count nationally.
Madhya Pradesh, meanwhile, hosts projects including a bulk drugs manufacturing unit at Pithampur, Dhar, promoted by Medilux Drugs Private Limited, which has received approvals. The state's industrial belt around Pithampur and Indore continues to attract capital from manufacturers seeking proximity to central India's logistics corridors.
Where Drugs and Pharmaceuticals Investment Is Concentrated
Across drugs and pharmaceuticals projects tracked in India, Projects India records 1,798 live projects in the sub-sector. The geographic distribution shows Gujarat leading with 607 tracked projects, followed by Telangana at 244, Andhra Pradesh at 231, Karnataka at 215, Maharashtra at 169, and Himachal Pradesh at 60.
For suppliers and contractors mapping opportunity by region, Gujarat and Telangana together account for roughly half of all tracked project locations in this sub-sector. Maharashtra, despite ranking fifth, remains significant given the size and scale of investments being announced there, as illustrated by the EKA Mobility development.
Pipeline by Stage: Where the Active Work Is
The stage breakdown of tracked projects provides a forward-looking picture of where procurement and construction activity is likely to intensify. Of the 1,798 projects Projects India tracks in drugs and pharmaceuticals:
- 637 are under approvals — representing the near-term pipeline where suppliers can begin early engagement
- 363 have commenced construction — the most immediate source of active procurement
- 323 are completed
- 139 are on hold
- 137 have received approvals and are moving toward construction
- 98 are in planning
With 15 projects added to the sub-sector in the last 90 days, the pipeline continues to grow. Suppliers targeting construction-stage projects will find the largest active cohort, while those focused on early-stage engagement should monitor the 637 projects still under approvals, which represent the next wave of construction demand.
Recent Project Activity in the Sub-Sector
Among recently tracked projects, construction has already started on an APIs and drug intermediates unit in Nashik, Maharashtra, promoted by Besi Drugs Private Limited at Rs 5.26 crore, and an API and API intermediates facility in Palghar, Maharashtra, promoted by Aadi Rishabh Chemicals LLP at Rs 10 crore. In Gujarat, VB Genetics Private Limited has begun construction on a bulk drugs unit at Ankleshwar valued at Rs 7 crore.
Larger projects moving through approvals include Aarti Pharmalabs Limited's Rs 154 crore API and API intermediates expansion at Palghar, Maharashtra, and Chromo Laboratories India Private Limited's Rs 195 crore bulk drug and intermediates expansion at Sangareddy, Telangana. These projects, once they clear approvals, will represent significant procurement opportunities for equipment suppliers and civil contractors. The full pipeline of tracked projects is available at Projects India's project database.
What this means for suppliers and contractors
The EKA Mobility inauguration in Madhya Pradesh and Maharashtra confirms that large-scale, multi-facility manufacturing investments are moving to completion in these states. For suppliers and contractors, the more immediate commercial opportunity lies in the 363 drugs and pharmaceuticals projects already in construction nationally, and the 137 that have received approvals and are likely to begin construction in the near term.
Maharashtra's active project count of 169 makes it a priority state for contractors already operating in the region. Madhya Pradesh's growing industrial base, including the Pithampur cluster, offers additional entry points. Gujarat remains the dominant state by volume, with 607 tracked projects across all stages, giving equipment makers and chemical suppliers the highest probability of concurrent procurement cycles in a single geography.
Suppliers tracking open tenders in the industrial projects sector can monitor live opportunities through Projects India's tender listings.
Frequently asked questions
How many manufacturing facilities has EKA Mobility inaugurated and where?
EKA Mobility has inaugurated six manufacturing facilities across Madhya Pradesh and Maharashtra. The development was reported by ET Auto on 30 October 2026 as part of a Rs 3,500 crore investment by the company across the two states.
How many drugs and pharmaceuticals projects are tracked in Maharashtra?
Projects India tracks 169 drugs and pharmaceuticals projects in Maharashtra, making it the fifth most active state in this sub-sector nationally, behind Gujarat at 607, Telangana at 244, Andhra Pradesh at 231, and Karnataka at 215.
What is the total size of the drugs and pharmaceuticals project pipeline in India?
Projects India tracks 1,798 live drugs and pharmaceuticals projects across India, with 15 added in the last 90 days. Of these, 363 have commenced construction and 637 are under approvals, representing the most active near-term procurement pipeline.
